Literature DB >> 19840019

Management of poor-prognosis or relapsed germ-cell cancer.

Gedske Daugaard1.   

Abstract

Entities:  

Mesh:

Year:  2009        PMID: 19840019     DOI: 10.1111/j.1464-410X.2009.08865.x

Source DB:  PubMed          Journal:  BJU Int        ISSN: 1464-4096            Impact factor:   5.588


× No keyword cloud information.
  2 in total

1.  Is high dose therapy superior to conventional dose therapy as initial treatment for relapsed germ cell tumors? The TIGER Trial.

Authors:  Darren R Feldman; Robert Huddart; Emma Hall; Jörg Beyer; Thomas Powles
Journal:  J Cancer       Date:  2011-07-01       Impact factor: 4.207

2.  Delayed rhabdomyolysis with paclitaxel, ifosfamide, carboplatin, and etoposide regimen: a case report.

Authors:  Alexandra Sokolova; Onyee Chan; Waqas Ullah; Auon Abbas Hamdani; Faiz Anwer
Journal:  J Med Case Rep       Date:  2017-04-11
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.